Affymetrix Names Kevin King President of Life Sciences Business
Affymetrix Inc. announced that it has appointed Kevin M. King to president of life sciences business and executive vice president, reporting to Stephen P.A. Fodor, Ph.D., chairman and CEO. King previously served as president and CEO of Thomson Healthcare, the $500 million healthcare and pharmaceutical information services division of Thomson Corporation.
King will be responsible for managing Affymetrix' growing life sciences business. He brings more than 25 years of industry experience to Affymetrix. At Thomson Healthcare, King was responsible for developing and implementing the growth strategy that led to its industry leading position within the $7 billion healthcare decision support market. King has also held senior executive positions at General Electric Healthcare, including vice president and general manager, Global Clinical Systems. In that position, he grew the business to more than $900 million in revenue through the global sales distribution expansion, introduction of new technologies and strategic acquisitions. In addition, King brings more than 14 years of experience at Hewlett-Packard, where his many accomplishments included the creation of a web-enabled systems strategy to help speed up the drug discovery process and reduce the time to complete clinical trials.
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
GE Healthcare Acquires Wave Biotech LLC - Broadening Capabilities in Growing Biopharmaceutical Manufacture Segment

Linseis Messgeräte GmbH - Selb, Germany
Allon granted U.S. patent for neurotoxicity caused by anti-cancer drugs
Almac Announces Expansion of Pharmaceutical Development Facilities
To-BBB obtains government loan of €1.2 million for clinical trial in brain cancer
Phylogica Peptide Fusion Kills Aggressive Breast Cancer Cells
VASTox identifiies novel compound that kill tubercolosis bacteria
